BLUEPRINT MEDICINES CORP revenue breakdown overview

BLUEPRINT MEDICINES CORP revenue for the last year amounted to 225.94 M EUR, the most of which — 225.94 M EUR — came from its highest performing source at the moment, Precision Therapies, the year earlier bringing 190.64 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BLUEPRINT MEDICINES CORP 205.79 M EUR, and the year before that — 177.78 M EUR.